Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.
CEO
Chairman Of The Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Anders Ericsson | 6,66 | 6,66 | 2021-02-08 |
| Anders Wall Stiftelser | 5,87 | 5,87 | 2021-02-08 |
| Magnus Lindroth | 5,74 | 5,74 | 2021-02-24 |
| Jan-Willem De Gier | 5,71 | 5,71 | 2021-02-08 |
| Joen Luirink | 5,58 | 5,58 | 2021-02-08 |
| John Moll | 4,90 | 4,90 | 2021-02-08 |
| Johan Källstrand | 4,20 | 4,20 | 2021-02-08 |
| Martin Ericsson | 3,64 | 3,64 | 2021-02-08 |
| Maria Alrikson | 2,48 | 2,48 | 2021-02-08 |
| Mårten Hellberg | 2,28 | 2,28 | 2021-02-08 |
2021-05-12 Delårsrapport 2021-Q1
2021-08-11 Delårsrapport 2021-Q2
2021-11-10 Delårsrapport 2021-Q3